Literature DB >> 23488940

The relationship between coronary sinus and impaired right ventricular myocardial performance index in mitral stenosis.

Mehmet Akif Vatankulu1, Fatih Koc, Enes Elvin Gul, Ahmet Bacaksiz, Osman Sonmez, Kenan Demir, Yusuf Alihanoglu, Hatem Ari, Selim Ayhan, Mehmet Tokac.   

Abstract

OBJECTIVES: We aimed to investigate whether coronary sinus (CS) dilatation develops in patients with mitral stenosis (MS) and to demonstrate its relationship with the global myocardial performance of the right ventricle (RV).
METHODS: We enrolled 34 patients with MS who underwent echocardiography after exhibiting typical symptoms (31 female; mean age 41 ± 12 years) and 20 age- and sex-matched controls without MS who underwent echocardiography (16 female; mean age 38 ± 13 years). The RV myocardial performance index (MPI) was detected using tissue Doppler echocardiography (TDE), and maximum CS diameter was measured from the posterior atrioventricular groove in the apical four-chamber view during the ventricular systole.
RESULTS: The RV MPI was significantly higher in the MS group compared to the control group (0.60 ± 0.11 vs. 0.41 ± 0.08, P < 0.001). Moreover, the maximum CS dimension was higher in the MS group compared to the control group (8.5 ± 1.1 mm vs. 6.5 ± 1.4 mm, P < 0.001). The maximum CS dilatation was positively correlated with the RV MPI (r = 0.691; P < 0.001).
CONCLUSION: The RV MPI, which represents both systolic and diastolic functions, is increased in patients with MS and correlates with CS dilatation.
© 2013, Wiley Periodicals, Inc.

Entities:  

Keywords:  coronary sinus; mitral stenosis; myocardial performance index; tissue Doppler echocardiography

Mesh:

Year:  2013        PMID: 23488940     DOI: 10.1111/echo.12157

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  1 in total

1.  Coronary sinus dilatation is a sign of impaired right ventricular function in patients with heart failure.

Authors:  Musa Çakıcı; Adnan Doğan; Mustafa Çetin; Arif Süner; Mustafa Polat; Muhammed Oylumlu; Erdal Aktürk; Sabri Abus; Fatih Üçkardeş
Journal:  Anatol J Cardiol       Date:  2014-06-23       Impact factor: 1.596

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.